Dr. Stefanie Hennig joined Certara Strategic Consulting as an Associate Director of Consulting Service in July 2019. She will be working as a consultant in PK and PK/PD modelling and simulation in various phases of drug development in a variety of population groups.
Stefanie has a Pharmacy and Master of Science degree from Germany and a PhD from the University of Queensland. She worked as a postdoc and researcher at Uppsala University in Sweden 2007-2010.
Before joining Certara, she held a tenured academic position at the University of Queensland (2011-2019) and was a senior fellow of the Humboldt Foundation, Germany. She has >60 peer reviewed publications, supervised and mentored > 20 higher research students and taught thousands of pharmacy students on PK/PD.
Stefanie is very active within the Pharmacometrics community worldwide, as the secretary of the Population Approach Group of Australia and New Zealand (PAGANZ), a member of the executive committee organizing the World Conference of Pharmacometrics (WCoP) and the Chair of the local organizing committee for WCoP2016. She has supported the Australian regulatory Therapeutic Goods Administration agency since 2014 as an advisor on the Pharmaceutical Subcommittee.
Her main research interests are around optimizing dosing in children and dose individualization using Bayesian forecasting. Main therapeutic areas of interest are cystic fibrosis, anti-infective, respiratory, oncology, TB and HIV.